Blizzard sent out the following
Earlier this year, we sold our first Overwatch charity skin: PINK MERCY. Now we are excited to share how the Breast Cancer Research Foundation has directed your generous funds and is advancing critical research to end breast cancer. Thanks to all of you, we were able to raise $12.7 million—the largest donation made by a corporate partner in a single year within BCRF’s 25-year history.
October marks Breast Cancer Awareness Month and, in the spirit of transparency, BCRF has graciously shared some insights on how the funds raised are being used to support research into understanding, preventing, and treating breast cancer.
THREE CRITICAL PROGRAMS
The donation of over $12.7 million will fuel three critical programs that examine every aspect of a breast cancer diagnosis and will change the lives of women and men across the globe.
- BCRF Precision Prevention Initiative
o BCRF will fuel innovative prevention research to reduce the incidence of breast cancer, including creating new tools and tests for improved screenings and diagnostics. These programs will advance the understanding of inherited risk and pursue population-based genetic risk assessment to help those deemed at risk before the disease takes place.
- BCRF Translational Breast Cancer Research Consortium Award
o The BCRF Translational Breast Cancer Research Consortium Award, funded by the Pink Mercy donations, will help launch five new clinical trials this year.
o These clinical trials are conducted within a consortium comprised of 19 medical institutions and nearly 200 investigators aimed at accelerating new treatments for patients with breast cancer.
- 25 Annual BCRF Research Grants
o Your donations will fund 25 research grants, which will be distributed to studies in seven different research fields that focus on diagnosis and treatment.
o The Blizzard Entertainment funded research grants will be distributed to 29 researchers in 10 US states and 8 total countries located in 6 different continents around the globe.
Did you take part?